Pregnancy should not delay cancer treatment, study suggests
the ONA take:
Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy due to concerns over harm to the fetus, a new study published online ahead of print in The New England Journal of Medicine has shown.
For the international, case-control study, researchers compared children age 12 to 42 months who mothers received a cancer diagnosis during pregnancy with matched children of women without cancer.
Of the 129 children identified, 96 were exposed to chemotherapy, 11 to radiotherapy, 13 to surgery alone, and 2 to other drug treatment. Fourteen were not exposed to treatment.
Results showed that prenatal exposure to maternal cancer with or without treatment did not negatively affect cardiac, cognitive, or general development of children in early childhood.
"Our results show that fear of cancer treatment is no reason to terminate a pregnancy, that maternal treatment should not be delayed and that chemotherapy can be given. The study also shows that children suffer more from prematurity than from chemotherapy, so avoiding prematurity is more important than avoiding chemotherapy," said lead author Frédéric Amant, MD, PhD, a gynecological oncologist at the University Hospitals Leuven in Belgium and at Antoni van Leeuwenhoek in The Netherlands.
Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|